| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90B | 33.53B | 30.11B | 27.04B | 24.51B | 21.27B |
| Gross Profit | 23.27B | 23.00B | 20.66B | 18.59B | 16.84B | 14.57B |
| EBITDA | 4.07B | 4.11B | 3.59B | 3.01B | 2.14B | 1.24B |
| Net Income | 2.19B | 2.31B | 2.09B | 1.65B | 1.04B | 348.12M |
Balance Sheet | ||||||
| Total Assets | 25.93B | 26.39B | 23.79B | 21.27B | 19.05B | 18.36B |
| Cash, Cash Equivalents and Short-Term Investments | 3.01B | 3.01B | 3.02B | 2.91B | 2.60B | 2.20B |
| Total Debt | 5.07B | 3.18B | 2.43B | 2.15B | 2.25B | 2.51B |
| Total Liabilities | 8.19B | 8.02B | 6.79B | 5.92B | 5.30B | 5.32B |
| Stockholders Equity | 17.63B | 18.27B | 16.90B | 15.28B | 13.69B | 13.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 822.66M | 737.75M | 1.13B | 963.62M | 670.60M |
| Operating Cash Flow | 0.00 | 2.14B | 1.87B | 1.77B | 1.48B | 1.13B |
| Investing Cash Flow | 0.00 | -1.84B | -1.20B | -820.75M | -219.54M | -312.63M |
| Financing Cash Flow | 0.00 | -334.41M | -587.97M | -714.03M | -899.69M | -480.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.80B | 14.03 | ― | 2.19% | 17.90% | 14.14% | |
74 Outperform | ¥28.47B | 8.12 | ― | 3.77% | 7.88% | -5.92% | |
66 Neutral | ¥22.04B | 10.52 | ― | 3.53% | -2.73% | -51.48% | |
65 Neutral | ¥207.85B | 40.03 | ― | 0.64% | 57.01% | 91.03% | |
64 Neutral | ¥33.13B | 11.19 | ― | 1.73% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥28.70B | 3.19 | ― | 0.95% | 4.14% | ― |